Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Keros Therapeutics (KROS)
NASDAQ:KROS
Holding KROS?
Track your performance easily
See the Price Targets and Ratings of:
KROS Analyst Ratings
Strong Buy
12 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
KROS Stock 12 Month Forecast
Average Price Target
$90.00
▲(58.95% Upside)
| Highest Price Target$107.00 | Average Price Target$90.00 | Lowest Price Target$76.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Leerink Partners
Reiterated
11/07/24
H.C. Wainwright
Reiterated
11/07/24
Piper Sandler
Reiterated
11/07/24
TD Cowen
Assigned
11/07/24
Wedbush
Reiterated
11/07/24
BTIG
Reiterated
11/06/24
Truist Financial
Reiterated
11/05/24
Jefferies
Initiated
11/05/24
Cantor Fitzgerald
Initiated
10/24/24
Scotiabank
Initiated
10/16/24
Guggenheim
$96
Buy
69.55%
Upside
Initiated
09/22/24
Keros Therapeutics: A Promising Bet on TGF-β Pathway Innovations and Management's Drug Development Acumen
Bank of America Securities
$81→$76
Buy
34.23%
Upside
Reiterated
09/12/24
Analysts Have Conflicting Sentiments on These Healthcare Companies: Medtronic (NYSE: MDT), Harmony Biosciences Holdings (NASDAQ: HRMY) and Keros Therapeutics (NASDAQ: KROS)
Oppenheimer
$102
Buy
80.15%
Upside
Reiterated
08/13/24
Oppenheimer Sticks to Its Buy Rating for Keros Therapeutics (KROS)
William Blair
$81
Buy
43.06%
Upside
Initiated
02/21/24
Keros Therapeutics initiated with an Outperform at William BlairKeros Therapeutics initiated with an Outperform at William Blair
Best Analysts Covering Keros Therapeutics
Which Analyst Should I Follow If I Want to Buy KROS and Sell After:
1 Month
xxx
Success Rate
12/20 ratings generated profit
Average Return
+8.02%
reiterated a xxx
rating 10 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 60.00% of your transactions generating a profit, with an average return of +8.02% per trade.
3 Months
xxx
Success Rate
8/12 ratings generated profit
Average Return
+9.26%
reiterated a xxx
rating 12 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +9.26% per trade.
1 Year
Success Rate
10/12 ratings generated profit
Average Return
+24.82%
reiterated a buy rating 12 days ago
Copying Srikripa Devarakonda's trades and holding each position for 1 Year would result in 83.33% of your transactions generating a profit, with an average return of +24.82% per trade.
2 Years
xxx
Success Rate
11/12 ratings generated profit
Average Return
+41.23%
reiterated a xxx
rating 12 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 91.67% of your transactions generating a profit, with an average return of +41.23% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
KROS Analyst Recommendation Trends
Rating
Jun 24
Aug 24
Sep 24
Oct 24
Nov 24
Strong Buy
10
11
11
5
4
Buy
9
7
7
7
12
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
19
18
18
12
16
Each month's total comprises the sum of three months' worth of ratings.
KROS Financial Forecast
KROS Stock Forecast FAQ
What is KROS’s average 12-month price target, according to analysts?
Based on analyst ratings, Keros Therapeutics’s 12-month average price target is $90.00.
What is KROS’s upside potential, based on the analysts’ average price target?
Keros Therapeutics has 58.95% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is KROS a Buy, Sell or Hold?
Keros Therapeutics has a consensus rating of Strong Buy which is based on 12 buy ratings, 0 hold ratings and 0 sell ratings.
What is Keros Therapeutics’s price target?
The average price target for Keros Therapeutics is $90.00. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $107.00 ,the lowest forecast is $76.00. The average price target represents 58.95% Increase from the current price of $56.62.
The highest analyst price target is $107.00 ,the lowest forecast is $76.00. The average price target represents 58.95% Increase from the current price of $56.62.
What do analysts say about Keros Therapeutics?
Keros Therapeutics’s analyst rating consensus is a Strong Buy. This is based on the ratings of 12 Wall Streets Analysts.
How can I buy shares of KROS?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.